News roundup Monday, December 16

bids on Abliva. Read more.

Medivir receives IND approval for fostrox. Read more.

Magle Group has approved the start of a multicenter study regarding EmboCept S for pain relief in osteoarthritis. Read more.

Orexo has resolved the patent dispute against Sun Pharmaceutical Industries for Zubsolv in the US. Read more.

Inify Laboratories carries out a directed issue of SEK 135 million. Read moreThe company is also making an offer to existing shareholders. Read more.

Cereno Scientific attends JPMorgan Health Week. Read moreNew preclinical data for CS585 presented at ASH Annual Meeting and Exposition 2024. Read more.

FDA provides EXACT Therapeutics IND for phase II study ENACT in pancreatic cancer. Read more.

Novo Holdings acquisition of Catalent gets the green light. Read more.

Novo Nordisk invests DKK 8,5 billion in new factory in Odense. Read more.

New names for AstraZeneca board. Read more.

Sedana Medical receives positive approval to include children in the indication for Sedaconda. Read more.

Saniona repays the remaining debt and converts convertibles into Fenja Capital IIRead more.

Lipigon appoints Johan Liwing to a new CEO. Read more.

Diamyd Medical in agreement with the FDA on key factors for an accelerated approval process. Read more.

Bavarian Nordic enters into a licensing agreement regarding its Mpox vaccine with the Serum Institute of India. Read more.

Pharma Equity Group decides on a new strategy in Reponex Pharmaceuticals. Read more.

Founder and board member participates in Phase Holographics ongoing issue. Read more.

Pila Pharma appoints a new CFO. Read more.

Princess Noura University Hospital in Riyadh, Saudi Arabia, signs agreements with clinics to measure SensoDetects Autism Spectrum Disorder Study. Read more.

Financial calendar

BBS-Bioactive Bone Substitutes  Vistin Pharma

Flaggings

Active Biotech  Bavarian Nordic  Observe Medical  ODI Pharma

Communiqués

SynAct Pharma

Presentations

Immunovia